Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative
Dexmedetomidine is a highly selective alpha 2 adrenoceptor agonist, having characteristics of natural sleep like sedation, can reduce pain intensity and opioid consumption without influencing the time of recovery from general anesthesia
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dexmedetomidine | Active Comparator | Dexmedetomidine 0.25 microgram per kilogram is used in Dacrocystorhinostomy patients 20 minutes before induction of general anesthesia |
|
| Control | No Intervention | Fentanyl as an analgesic is used with general anesthesia in Dacrocystorhinostomy patients |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexmedetomidine Hydrochloride | Drug | drug will be given before induction and anesthetic doses and hemodynamics will be assessed pre- intra and postoperative |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maintained hemodynamic values while reducing the anesthetic requirements | Measuring the heart rate and the blod pressure every 5 minutes intraoperative and for half an hour postoperative to assess hemodynamic stability | from 20 minutes after administering the drug till 2 hours after full recovery |
| Measure | Description | Time Frame |
|---|---|---|
| Delerium | Reducing postoperative delirium in elderly patients | from 20 minutes after administering the drug till 2 hours after full recovery |
Not provided
Inclusion Criteria:
patients of both sexes 16 years to 75 years of age ASA (American society of Anesthesiologists) I-III
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dina Moustafa Mohamed Ali, MD | Contact | 01113981021 | dina.moustafa.ali@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Institute of Ophthalmolgy | Recruiting | Giza | Egypt |
Not provided
2 Groups, Dexmedetomidine group and control group are assigned
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020927 | Dexmedetomidine |
| ID | Term |
|---|---|
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided